PATIENT SAFETY ARTICLE
October 20, 2024

Mpox: An Update on the New Public Health Emergency

​​​​AUTHOR BIOGRAPHIES

Christine Bingman, DNP, RN, Patient Safety Authority
Christine Bingman is a registered nurse and an infection preventionist for the Patient Safety Authority.

Denise Cutting, MSN, MSH, RN, Patient Safety Authority
Denise Cutting (dcutting@pa.gov) is a registered nurse and an infection preventionist for the Patient Safety Authority.

*Corresponding author

Abstract

Mpox, previously known as monkeypox virus, is an infectious disease spread through close contact and respiratory droplets. Exposure to the virus can occur during travel to an area with sustained human-to-human transmission; contact with a confirmed, probable, or suspected case; contact with a dead or live wild animal or exotic pet that is a central African endemic species; or use of a product derived from such animals (e.g., game meat, creams, lotions, powders, etc.). Mpox symptoms typically start within 21 days of exposure with influenza-like symptoms, followed by a vesicular or pustular rash one to four days later. The rash is generally located on the palms of hands, soles of feet, genitalia, and anus.